Helus Pharma Statistics
NASDAQ: HELPHealthcareBiotechnologyUSD
10.51-0.25 (-2.32%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Helus Pharma by the numbers
Helus Pharma has a market capitalization of $767.9 million based on 73.06M shares outstanding. With trailing EPS of $-4.06, Helus Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.9% below its 50-day average and 41.1% above its 200-day average.
Average daily trading volume is 1.79M shares, or about $18.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HELP valuation vs. peer median
| Metric | HELP | Peer median | Difference |
|---|---|---|---|
| Market cap | $767.86M | $765.59M | +0% |
| Avg. volume | 1.79M | 1.68M | +6% |
Peer median across 8 companies: GERN, DNA, ANNX, LXRX, CADL, APMD, ATTO, IMMX.
Valuation
- Market cap
- $767.86M
- EPS (TTM)
- $-4.06
- Shares outstanding
- 73.06M
Price and trading
- Previous close
- 10.76
- Open
- 10.63
- Day range
- 10.44 – 10.81
- 52-week range
- 3.76 – 15.15
- 52-week change
- +73.15%
- Beta
- —
- Volume
- 817.14K
- Average volume
- 1.79M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 767.86M
- Forward Pe
- -5.88
- Eps
- -4.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.15
- Week52 Low
- 3.76
- Avg Volume
- 1.79M
- Shares Outstanding
- 73.06M
- Ma50
- 11.80
- Ma200
- 7.45
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -30.63%
- Pct From52w Low
- 179.52%